FDA panel recommends testosterone therapy be more accessible to men, knocks ‘outdated’ restrictions

The narrow FDA labeling makes it so that only a minority of men who could benefit from treatment are considered ‘on-label’ ...

Nasal spray sold nationwide recalled due to mold, ‘life-threatening' infections possible, FDA says

The voluntary recall of ReBoost Nasal Spray was issued Wednesday by MediNatura New Mexico, according to an announcement from ...
Becker's Hospital Review

FDA panel pushes to reclassify testosterone therapy

An FDA panel pushes reclassify testosterone therapy by recommending removal of controlled substance status and expanding treatment eligibility.